| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 14 / 328 | 95th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy is Scopus-indexed (Q1, CiteScore 15.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 0753-3322Verify ISSN ↗1950-6007Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas
Quick answers
Is Biomedicine and Pharmacotherapy indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1982–present, best quartile Q1, CiteScore 15.9.
What quartile is Biomedicine and Pharmacotherapy in Scopus?
Biomedicine and Pharmacotherapy is Q1 in Pharmacology (rank 14 of 328), by CiteScore 2025.
What is the impact factor of Biomedicine and Pharmacotherapy?
Biomedicine and Pharmacotherapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 15.9, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.074, quartile Q1, with an H-index of 196.
How much does it cost to publish in Biomedicine and Pharmacotherapy?
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$3,610 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Biomedicine and Pharmacotherapy and what is its ISSN?
Biomedicine and Pharmacotherapy is published by Elsevier Masson s.r.l. Its print ISSN is 0753-3322 and its online ISSN is 1950-6007.
Is Biomedicine and Pharmacotherapy covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS also covers its article processing charge for authors at eligible institutions.
Is Biomedicine and Pharmacotherapy in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Biomedicine and Pharmacotherapy open access?
Yes — it is an open-access journal per Scopus.
How well cited is Biomedicine and Pharmacotherapy? — open metrics via OpenAlex
Biomedicine and Pharmacotherapy has an h-index of 227 and a 2-year mean of 8.52 citations per paper (OpenAlex). Its Scopus CiteScore is 15.9, quartile Q1. On 2-year citations it ranks #13 of 319 Scopus journals in Pharmacology.
Biomedicine and Pharmacotherapy published 1,074 papers in 2025; its busiest recent year was 2018 with 2,021. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Biomedicine and Pharmacotherapy? — latest 95 articles, 2026
In its latest 95 research articles (2026), authors are most often from China (23%), Brazil (10.2%) and India (6.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Biomedicine and Pharmacotherapy? — indicators, not proof of misconduct
Scopus status: Active. 499 retracted papers are recorded (24 per 1,000 papers). The Problematic Paper Screener flags 36 of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 499 · 24 per 1,000 papers
- Problematic Paper Screener flags 36 · 1.7 per 1,000 papers — mostly tortured phrases and suspect text
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.